Increased risk of cardiometabolic disease in normal-weight individuals with non-alcoholic fatty liver disease
出版年份 2023 全文链接
标题
Increased risk of cardiometabolic disease in normal-weight individuals with non-alcoholic fatty liver disease
作者
关键词
-
出版物
Obesity Research & Clinical Practice
Volume -, Issue -, Pages -
出版商
Elsevier BV
发表日期
2023-09-28
DOI
10.1016/j.orcp.2023.09.003
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Nonalcoholic Fatty Liver Disease (NAFLD) is Independently Associated with Higher All-Cause and Cause-Specific Mortality
- (2023) Leyla de Avila et al. Clinical Gastroenterology and Hepatology
- Higher mortality among lean patients with non‐alcoholic fatty liver disease despite fewer metabolic comorbidities
- (2023) Karn Wijarnpreecha et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Lean individuals with NAFLD have more severe liver disease and poorer clinical outcomes (NASH-CO Study)
- (2023) Oumarou Nabi et al. HEPATOLOGY
- Metabolically unhealthy phenotype in adults with normal weight: Is cardiometabolic health worse off when compared to adults with obesity?
- (2023) Myong-Won Seo et al. Obesity Research & Clinical Practice
- Epidemiology and Prevalence of Lean Non‐Alcoholic Fatty Liver Disease and Associated Cirrhosis, HCC and Cardiovascular Outcomes in the United States: A Population‐Based Study and Review of Literature
- (2022) Ashraf Almomani et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
- (2022) Kiarash Riazi et al. Lancet Gastroenterology & Hepatology
- NASH/liver fibrosis prevalence and incidence of non-liver comorbidities among people with NAFLD and incidence of NAFLD by metabolic comorbidites: Lessons from South Korea
- (2021) Jiyoon Park et al. DIGESTIVE DISEASES
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- Hepatic Fibrosis Associates With Multiple Cardiometabolic Disease Risk Factors: The Framingham Heart Study
- (2020) Michelle T. Long et al. HEPATOLOGY
- Genetics and epigenetics of NAFLD and NASH: Clinical impact
- (2018) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Association between body mass index and fatty liver risk: A dose-response analysis
- (2018) Rui Fan et al. Scientific Reports
- The triglyceride and glucose index (TyG) is an effective biomarker to identify nonalcoholic fatty liver disease
- (2017) Shujun Zhang et al. Lipids in Health and Disease
- Estimated carotid–femoral pulse wave velocity has similar predictive value as measured carotid–femoral pulse wave velocity
- (2016) Sara V. Greve et al. JOURNAL OF HYPERTENSION
- Nonalcoholic Fatty Liver Disease and Vascular Function: Cross-Sectional Analysis in the Framingham Heart Study
- (2015) M. T. Long et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Relationship of sitting time and physical activity with non-alcoholic fatty liver disease
- (2015) Seungho Ryu et al. JOURNAL OF HEPATOLOGY
- Development of non-alcoholic fatty liver disease scoring system among adult medical check-up patients: a large cross-sectional and prospective validation study
- (2015) Cosmas Lesmana et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Pregravid Liver Enzyme Levels and Risk of Gestational Diabetes Mellitus During a Subsequent Pregnancy
- (2014) Sneha B. Sridhar et al. DIABETES CARE
- Metabolic pathways promoting intrahepatic fatty acid accumulation in methionine and choline deficiency: implications for the pathogenesis of steatohepatitis
- (2010) David P. Macfarlane et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Visceral Adiposity Index: A reliable indicator of visceral fat function associated with cardiometabolic risk
- (2010) M. C. Amato et al. DIABETES CARE
- Diagnosis and Classification of Diabetes Mellitus
- (2010) DIABETES CARE
- Hepatic steatosis index: A simple screening tool reflecting nonalcoholic fatty liver disease
- (2009) Jeong-Hoon Lee et al. DIGESTIVE AND LIVER DISEASE
- Resveratrol inhibits nonalcoholic fatty liver disease in rats
- (2008) Luis Bujanda et al. BMC GASTROENTEROLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search